# A Study to Evaluate the Efficacy and Safety of TF0023 Spray on Subjects With Ischemic Strokes

Study · id `cardio:ct-nct02785120` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02785120](<https://clinicaltrials.gov/study/NCT02785120>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02785120

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is suspended. It plans to enroll 225 participants.

## Technical summary

Registry record NCT02785120. Randomized; triple masking; primary purpose treatment. Start 2017-03-01 (actual); primary completion 2024-10 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; triple masking; primary purpose treatment
- Phase: Phase 2
- Enrolled: 225 participants (planned count; ClinicalTrials.gov record NCT02785120, source copy `cardio:ctgov-nct02785120-2024-01-05`, retrieved 2026-10-26)
- Started: 2017-03-01 (actual) (ClinicalTrials.gov record NCT02785120, source copy `cardio:ctgov-nct02785120-2024-01-05`, retrieved 2026-10-26)
- Primary completion: 2024-10 (anticipated) (ClinicalTrials.gov record NCT02785120, source copy `cardio:ctgov-nct02785120-2024-01-05`, retrieved 2026-10-26)
- Completion: 2024-12 (anticipated) (ClinicalTrials.gov record NCT02785120, source copy `cardio:ctgov-nct02785120-2024-01-05`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT02785120, source copy `cardio:ctgov-nct02785120-2024-01-05`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "SUSPENDED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02785120-2024-01-05`, retrieved 2026-10-26)

## The registry's words

- Brief title: A Study to Evaluate the Efficacy and Safety of TF0023 Spray on Subjects With Ischemic Strokes
- Acronym: TF0023
- Condition: Ischemic Stroke
- Intervention (Drug): TF0023
- Lead sponsor: Techfields Inc
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Ischemic stroke (`cardio:ischemic-stroke`)
- Registry condition terms include this condition: Stroke (`core:stroke`)

## Provenance

Content hash: 8e846642ad604eea047b26630adc63a456d748ed538b3d14c4817ee0802c52f0
Last substantive edit: 2026-10-31
Evidence last checked: Not recorded
